Skip to main content
Aurobindo Pharma Limited (NSE: AUROPHARMA)
India flag India · Delayed Price · Currency is INR
1,171.30
+45.90 (4.08%)
Feb 4, 2025, 3:30 PM IST

Aurobindo Pharma Revenue

Aurobindo Pharma had revenue of 77.96B INR in the quarter ending September 30, 2024, with 7.99% growth. This brings the company's revenue in the last twelve months to 302.95B, up 12.41% year-over-year. In the fiscal year ending March 31, 2024, Aurobindo Pharma had annual revenue of 290.02B with 16.68% growth.

Revenue (ttm)
302.95B
Revenue Growth
+12.41%
P/S Ratio
2.26
Revenue / Employee
11.65M
Employees
26,015
Market Cap
680.29B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024290.02B41.46B16.68%
Mar 31, 2023248.55B14.00B5.97%
Mar 31, 2022234.55B-13.19B-5.32%
Mar 31, 2021247.75B16.76B7.26%
Mar 31, 2020230.99B35.35B18.07%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 516.03B
Divi's Laboratories 86.14B
Cipla 267.20B
Mankind Pharma 116.41B
Apollo Hospitals Enterprise 204.69B
Zydus Lifesciences 214.84B
Alkem Laboratories 128.32B
Fortis Healthcare 73.13B
Revenue Rankings

Aurobindo Pharma News

More News